英文名稱 Anti-CCL4/MIP-1 Beta

中文名稱 巨噬細胞炎性蛋白1β抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來源 Rabbit

交叉反應(yīng) Human, Mouse, Rat

產(chǎn)品類型 一抗

研究領(lǐng)域 腫瘤 細胞生物 免疫學 轉(zhuǎn)錄調(diào)節(jié)因子

蛋白分子量 predicted molecular weight: 7.8kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from mouseCCL4

亞 型 IgG

純化方法 affinity purified by Protein A

儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件  Store at -20 °C for one year.

別 名 Macrophage Inflammatory Protein 1 beta; MIP-1 Beta;MIP-1β; Secreted protein G 26; ACT 2; ACT2; AT744.1; CCchemokine ligand 4; CCL4; ccl4l 1; CCL4L1; Chemokine CC Motif Ligand 4; G 26 Tlymphocyte secreted protein; HC21; LAG 1; LAG1; Lymphocyte activation gene 1;Lymphocyte activation gene 1 protein; Macrophage inflammatory protein 1 beta;MGC104418; MGC126025; MGC126026; MIP1 beta; MIP1B; MIP1B1; PAT 744; ProteinH400; SCYA2; SCYA4; Secreted protein G26; SIS gamma; Small inducible cytokineA4; T cell activation protein 2; CCL4_HUMAN;